Identification in daily practice of patients with lynch syndrome (hereditary nonpolyposis colorectal cancer): Revised Bethesda guidelines-based approach versus molecular screening

American Journal of Gastroenterology

Volumn 103, Issue 11, 2008, Pages 2825-2835

  Julié, Catherine ^a   Trésallet, Christophe ^a,b   Brouquet, Antoine ^a,c   Vallot, Céline ^c   Zimmermann, Ute ^a   Mitry, Emmanuel ^a   Radvanyi, François ^c   Rouleau, Etienne ^d   Lidereau, Rosette ^d   Coulet, Florence ^b   Olschwang, Sylviane ^e   Frébourg, Thierry ^f   Rougier, Philippe ^a   Nordlinger, Bernard ^a   Laurent Puig, Pierre ^a,g   Penna, Christophe ^a   Boileau, Catherine ^a   Franc, Brigitte ^a   Muti, Christine ^h   Hofmann Radvanyi, Hélène ^a,h  

^a LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT CURIE   (France)

^d CENTRE RENÉ HUGUENIN   (France)

^e INSTITUT PAOLI CALMETTES   (France)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g INSERM   (France)

^h HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA; MISMATCH REPAIR PROTEIN; PROTEIN MLH1;

ADULT; AGED; ARTICLE; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; CLINICAL PRACTICE; COLORECTAL CANCER; CONTROLLED STUDY; DNA EXTRACTION; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOLECULAR BIOLOGY; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 55349099844     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2008.02084.x     Document Type: Article

References (47)

1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003 348 : 919 32.
2. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004 10 : 769 80.
3. Lynch HT, Boland CR, Gong G, et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: Diagnostic, surveillance and management implications. Eur J Hum Genet 2006 14 : 390 402.
4. Jass JR. Hereditary non-polyposis colorectal cancer: The rise and fall of a confusing term. World J Gastroenterol 2006 12 : 4943 50.
5. Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999 81 : 214 8.
6. Hampel H, Stephens JA, Pukkala E, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: Later age of onset. Gastroenterology 2005 129 : 415 21.
7. Jass JR, Smyrk TC, Stewart SM, et al. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994 14 : 1631 4.
8. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997 113 : 1146 58.
9. Kolodner RD, Tytell JD, Schmeits J, et al. Germline MSH6 mutations in colorectal cancer families. Cancer Res 1999 59 : 5068 74.
10. Wu Y, Berends MJ, Mensink RG, et al. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. Am J Hum Genet 1999 65 : 1291 8.
11. Wagner A, Hendriks Y, Meijers-Heijboer EJ, et al. Atypical HNPCC owing to MSH6 germline mutations: Analysis of a large Dutch pedigree. J Med Genet 2001 38 : 318 22.
12. Liu T, Yan H, Kuismanen S, et al. The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res 2001 61 : 7798 802.
13. Hendriks YM, Jagmohan-Changur S, van der Klift HM, et al. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology 2006 130 : 312 22.
14. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993 260 : 812 6.
15. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997 57 : 808 11.
16. Jarvinen HJ, Aarnio M, Mustonen H, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000 118 : 829 34.
17. de Jong AE, Hendriks YM, Kleibeuker JH, et al. Decrease in mortality in Lynch syndrome families because of surveillance. Gastroenterology 2006 130 : 665 71.
18. Vasen HF, Mecklin JP, Khan PM, et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991 34 : 424 5.
19. Vasen HF, Watson P, Mecklin JP, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 1999 116 : 1453 6.
20. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997 89 : 1758 62.
21. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004 96 : 261 8.
22. Umar A, Risinger JI, Hawk ET, et al. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004 4 : 153 8.
23. Wang L, Cunningham JM, Winters JL, et al. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair. Cancer Res 2003 63 : 5209 12.
24. Domingo E, Laiho P, Ollikainen M, et al. BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet 2004 41 : 664 8.
25. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 2005 352 : 1851 60.
26. Boland CR, Thibodeau SN, Hamilton SR, et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998 58 : 5248 57.
27. Rigau V, Sebbagh N, Olschwang S, et al. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6. Arch Pathol Lab Med 2003 127 : 694 700.
28. den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 2000 15 : 7 12.
29. Xiong Z, Laird PW. COBRA: A sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997 25 : 2532 4.
30. Fransen K, Klintenas M, Osterstrom A, et al. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 2004 25 : 527 33.
31. Charbonnier F, Olschwang S, Wang Q, et al. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Cancer Res 2002 62 : 848 53.
32. Obmolova G, Ban C, Hsieh P, et al. Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature 2000 407 : 703 10.
33. Shimodaira H, Filosi N, Shibata H, et al. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet 1998 19 : 384 9.
34. Charbonnier F, Raux G, Wang Q, et al. Detection of exon deletions and duplications of the mismatch repair genes in hereditary nonpolyposis colorectal cancer families using multiplex polymerase chain reaction of short fluorescent fragments. Cancer Res 2000 60 : 2760 3.
35. Gologan A, Krasinskas A, Hunt J, et al. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med 2005 129 : 1390 7.
36. Piñol V, Castells A, Andreu M, et al., for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005 293 : 1986 94.
37. Wolf B, Gruber S, Henglmueller S, et al. Efficiency of the revised Bethesda guidelines (2003) for the detection of mutations in mismatch repair genes in Austrian HNPCC patients. Int J Cancer 2006 118 : 1465 70.
38. Rodriguez-Moranta F, Castells A, Andreu M, et al., for the Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: Proposal of a new and simpler set of recommendations. Am J Gastroenterol 2006 101 : 1104 11.
39. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998 338 : 1481 7.
40. Salovaara R, Loukola A, Kristo P, et al. Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 2000 18 : 2193 200.
41. Mitchell RJ, Brewster D, Campbell H, et al. Accuracy of reporting of family history of colorectal cancer. Gut 2004 53 : 291 5.
42. Berends MJ, Wu Y, Sijmons RH, et al. Molecular and clinical characteristics of MSH6 variants: An analysis of 25 index carriers of a germline variant. Am J Hum Genet 2002 70 : 26 37.
43. Lagerstedt Robinson K, Liu T, Vandrovcova J, et al. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. J Natl Cancer Inst 2007 99 : 291 9.
44. Lindor NM, Rabe K, Petersen GM, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 2005 293 : 1979 85.
45. Barnetson RA, Tenesa A, Farrington SM, et al. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006 354 : 2751 63.
46. Chen S, Wang W, Lee S, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA 2006 296 : 1479 87.
47. Balmana J, Stockwell DH, Steyerberg EW, et al. Prediction of MLH1 and MSH2 in Lynch syndrome. JAMA 2006 296 : 1469 78.